Agilent Technologies will collaborate with Dr Shane Snyder ? an internationally recognized authority on water contamination from the University of Arizona?s Department of Chemical and Environmental Engineering ? and the university?s BIO5 Institute to develop new methods of detecting emerging contaminants in water, according to a company press release.
Agilent Technologies will collaborate with Dr Shane Snyder — an internationally recognized authority on water contamination from the University of Arizona’s Department of Chemical and Environmental Engineering — and the university’s BIO5 Institute to develop new methods of detecting emerging contaminants in water, according to a company press release.
Emerging contaminants can include pharmaceuticals, personal care products and other commonly used substances. The collaboration aims to increase the ability to accurately detect contamination in water supplies.
Dr Snyder commented that the partnership with Agilent will allow the University of Arizona to more effectively influence water reuse and desalination strategies by ensuring that the required water quality has been achieved for its intended use.
“Not only will we investigate known potential threats to water quality, we will also bridge the gap between detection and health by developing methodologies that can screen water for toxicity from multiple compounds,” he said.
The concept of addressing contaminants in potable water as mixtures — instead of separate chemicals— is of great interest to the regulatory, scientific and public communities.
The collaboration will be centered at the BIO5 Institute on the University of Arizona campus, where the infrastructure for cross-disciplinary work combining biological and chemical research already exists.
The BIO5 Institute at the University of Arizona mobilizes top researchers in five disciplines — agriculture, engineering, medicine, pharmacy and basic science — to find solutions to important health and environmental problems.
For more information, visit www.engineering.arizona.edu, www.bio5.org or www.agilent.com
This story originally appeared in The Column. Click here to view that issue.
Analyzing Effects of Adverse Cardiovascular Events on Chronic Kidney Disease with HPLC
March 13th 2025Researchers investigated the potential association between plasma apolipoprotein M (APOM) levels and the risk of adverse cardiovascular outcomes in individuals with chronic kidney disease (CKD). Plasma sphingosine-1-phosphate (S1P) levels were measured by high performance liquid chromatography (HPLC).
New Study Investigates Optimizing Extra-Column Band Broadening in Micro-flow Capillary LC
March 12th 2025Shimadzu Corporation and Vrije Universiteit Brussel researchers recently investigated how extra-column band broadening (ECBB) can be optimized in micro-flow capillary liquid chromatography.